Investors

Financials

v3.26.1
Condensed Consolidated Balance Sheets
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
CURRENT ASSETS:    
Cash $ 443,702 $ 12,088
GST tax receivable 11,057 5,302
Prepaid expenses - current portion 7,733,625 8,334,046
Other current assets 35,104 1,380
TOTAL CURRENT ASSETS 8,223,488 8,352,816
Deferred offering costs 291,773
Prepaid expenses - long-term portion 6,057,422 10,925,835
Security deposit - related party 2,065 1,971
Operating lease right-of-use assets, net - related party 46,584 59,413
Property and equipment, net 4,221
TOTAL ASSETS 14,333,780 19,631,808
CURRENT LIABILITIES:    
Accounts payable 973,692 1,249,596
Accrued expenses and other payables 942,376 1,486,550
Accrued interest 123,181 190,795
Notes payable, net of discount 543,312
Convertible notes, net of discounts and including put premiums 55,000 537,921
Operating lease liability - related party, current portion 23,324 17,664
Warrant liability 104,313
Embedded conversion option liabilities 50,273 403,892
Employee benefit liability 738,187 667,901
TOTAL CURRENT LIABILITIES 3,475,628 5,578,240
NON-CURRENT LIABILITIES:    
Loan payable - long-term - related party, net of discount 105,627
Operating lease liability - long-term portion - related party 30,267 41,749
TOTAL NON-CURRENT LIABILITIES 30,267 147,376
TOTAL LIABILITIES 3,505,895 5,725,616
Temporary Equity – Convertible Preferred Stock Series C - $0.01 par value, $10,000 stated value, 9,900 shares designated and authorized, 100 (liquidation value of $1,000,000) and none issued and outstanding at March 31, 2026 and June 30, 2025, respectively 1,000,000
Commitments and Contingencies (See Note 9)
STOCKHOLDERS’ EQUITY:    
Common stock, $0.001 par value; 10,000,000,000 shares authorized; 21,859,281 and 11,611,782 shares issued and outstanding as of March 31, 2026 and June 30, 2025, respectively 21,860 11,612
Common stock issuable (33,007,750 and 7,750 shares as of March 31, 2026 and June 30, 2025, respectively) 33,008 8
Additional paid-in capital 149,427,962 138,243,652
Accumulated other comprehensive income 1,234,766 1,318,917
Accumulated deficit (140,843,234) (125,621,520)
Treasury stock ($0.001 share) (46,477) (46,477)
TOTAL STOCKHOLDERS’ EQUITY 9,827,885 13,906,192
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY 14,333,780 19,631,808
Series A Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY:    
Preferred stock, value
Series B Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY:    
Preferred stock, value
Nonrelated Party [Member]    
CURRENT LIABILITIES:    
Loans payable 65,280
Related Party [Member]    
CURRENT LIABILITIES:    
Loans payable 465,282 415,329
NON-CURRENT LIABILITIES:    
Loan payable - long-term - related party, net of discount $ 0 $ 105,627

Source

v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
REVENUE        
Revenue
OPERATING EXPENSES        
Administration expenses (including noncash compensation expense of $11,581,251 and $52,853,115 for the nine months ended March 31, 2026 and 2025, respectively, and $5,351,136 and $52,838,115 for the three months ended March 31, 2026 and 2025, respectively. 6,219,644 53,068,147 14,446,391 53,442,499
Occupancy expenses - related party 10,917 6,469 32,306 20,187
Research and development 169,660 54,097 249,822 170,199
TOTAL OPERATING EXPENSES 6,400,221 53,128,713 14,728,519 53,632,885
LOSS FROM OPERATIONS (6,400,221) (53,128,713) (14,728,519) (53,632,885)
OTHER INCOME (EXPENSE)        
Interest expense (38,270) (104,042) (402,874) (309,215)
Interest income 13 1 69 2
Derivative expense (59,271) (95,012)
Change in fair value of derivative liabilities (18,146) 47,119 49,876 113,487
Change in fair value of warrant liability 182,517 776,227
Other expense 43,000 (11,000)
Settlement expense (90,000) (90,000)
Gain (loss) on extinguishment of debt, net (74,235) (809,954) 135,943 (840,032)
Foreign currency transaction gain (loss) 35,006 (12,486) (19,190) (88,184)
TOTAL OTHER INCOME (EXPENSE), NET 39,885 (938,633) 439,051 (1,218,954)
LOSS BEFORE TAXES (6,360,336) (54,067,346) (14,289,468) (54,851,839)
Tax benefit
NET LOSS (6,360,336) (54,067,346) (14,289,468) (54,851,839)
Deemed Dividend (932,246)
NET LOSS $ (6,360,336) $ (54,067,346) $ (15,221,714) $ (54,851,839)
BASIC NET LOSS PER SHARE $ (0.28) $ (12.50) $ (0.95) $ (38.62)
DILUTED NET LOSS PER SHARE $ (0.28) $ (12.50) $ (0.95) $ (38.62)
BASIC WEIGHTED AVERAGE SHARES OUTSTANDING 22,427,486 4,325,994 15,973,535 1,420,307
DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING 22,427,486 4,325,994 15,973,535 1,420,307
OTHER COMPREHENSIVE INCOME (LOSS)        
Unrealized foreign currency translation gain (loss) $ (93,349) $ (27,311) $ (84,151) $ 194,976
TOTAL OTHER COMPREHENSIVE INCOME (LOSS) (93,349) (27,311) (84,151) 194,976
TOTAL COMPREHENSIVE LOSS $ (6,453,685) $ (54,094,657) $ (15,305,865) $ (54,656,863)

Source

v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2026
Sep. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Mar. 31, 2026
Mar. 31, 2025
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:              
Net loss $ (6,360,336) $ (4,837,738) $ (54,067,346) $ (354,310) $ (14,289,468) $ (54,851,839)  
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:              
Issuance of common stock for services         741,248 51,348,000  
Common stock issuable for services         3,570,000  
Amortization of prepaid stock based expenses         7,270,003 1,505,115  
Foreign currency transaction loss         19,190 88,184  
Depreciation expense 316   0   670  
Amortization of debt discounts         198,362 193,283  
Amortization of right-of-use assets         15,650 14,952  
Change in fair value of derivative liabilities 18,146   (47,119)   (49,876) (113,487)  
Change in fair value of warrant liability (182,517)     (776,227)  
Derivative expense   59,271   95,012  
 Loss (gain) on extinguishment of debt, net 74,235   809,954   (135,943) 840,032  
Non-cash interest expense         5,843 5,519  
Accretion of put premium         37,450  
Changes in Assets and Liabilities:              
GST receivable         (5,504) (880)  
Prepaid expenses         (68,669) 1,312  
Other current assets         (33,659)  
Accounts payable         (335,235) 118,706  
Employee benefit liability         38,573 27,917  
Accrued expenses and other payables         (308,783) 342,223  
Accrued interest         34,365 89,179  
Operating lease liability         (8,643) (16,210)  
NET CASH USED IN OPERATING ACTIVITIES         (4,080,653) (312,982)  
CASH FLOWS FROM INVESTING ACTIVITIES:              
Purchase of equipment         (4,912)  
NET CASH USED IN INVESTING ACTIVITIES         (4,912)  
CASH FLOWS FROM FINANCING ACTIVITIES:              
Proceeds from convertible promissory notes, net of original issue discounts and issue costs         100,000 150,000  
Proceeds from issuance of convertible Series C Preferred stock, net of issuance cost         950,099  
Proceeds from exercise of Series C warrants         1,000,000  
Repayment of convertible notes         (203,350) (8,000)  
Repayment of notes         (671,777) (98,400)  
Repayment of loans payable - related party         (169,194)  
Proceeds from the sale of common stock, net of offering costs         3,314,458  
Proceeds from note payable         75,000 145,000  
Proceeds from loans payable - related parties         78,249 294,400  
Deferred offering costs         (65,000)  
NET CASH PROVIDED BY FINANCING ACTIVITIES         4,473,485 418,000  
Effect of exchange rate changes on cash         43,694 (75,343)  
NET INCREASE IN CASH         431,614 29,675  
CASH AT BEGINNING OF PERIOD   $ 12,088   $ 21,085 12,088 21,085 $ 21,085
CASH AT END OF PERIOD $ 443,702   $ 50,760   443,702 50,760 $ 12,088
Cash paid during the period:              
Interest         126,855 21,625  
Income Tax          
Supplemental Disclosure of Non-Cash Investing and Financing Activities              
Reduction of put premium related to conversions of convertible notes         114,399 10,229  
Conversion of convertible notes and accrued interest to common stock         416,291 79,686  
Settlement of accounts payable for shares of common stock         129,354  
Settlement of loans to former director for shares of common stock         74,395  
Settlement of loans payable including accrued interest for shares of common stock         125,765 86,248  
Defferred offering cost charged to additional paid in capital upon closing of offering         291,773  
Issuance of common stock related to debt exchange agreement         125,764  
Debt discounts related to derivative liability         150,000  
Issuance of common stock and common stock issuable for prepaid services (net of amortized portion)         1,026,729 22,375,995  
Deemed dividend related to Series C Preferred Stock         932,246  
Reclassification of warrant liability into equity upon exercise of Series C warrants         $ 1,805  

Source

Sign up for email alerts

Be the first to receive breaking news

Sign up today